期刊文献+

艾滋病毒1型逆转录酶抑制剂的小鼠血清活性动态研究 被引量:3

Dynamic Study of HIV-1 Reverse Transcriptase Inhibitor in Serum Activity of Mice
下载PDF
导出
摘要 目的:观察艾滋病毒1型逆转录酶(HIV-1RT)抑制剂在小鼠血清中的活性动态,探讨其在药效评价中的可应用性。方法:不同途径给予小鼠已知和未知HIV-1RT抑制剂后,在不同时间取血分离血清,体外测定血清抑制 HIV-1RT的活性。结果:正常小鼠血清有非特异性抑制HIV-1RT的活性,经稀释后可排除;非核苷类RT抑制剂可在体外直接测定小鼠体内用药后的血清抑制HIV-1RT活性和动态,核苷类RT抑制剂的血清抗HIV-1RT的活性可测出,但血清活性不如非核苷类药物为高,主要因核苷类药物的活性物质是其三磷酸盐,在细胞内转化后形成。此种体外测定小鼠用药后血清活性的体内体外结合的实验方法,简便快速,可初步分析药物与血清蛋白的结合率以及估算其生物利用度和清除率。结论:体内与体外相结合的逆转录酶抑制剂的小鼠血清活性的测定方法,可应用于非核苷类HIV-1RT抑制剂的药效评价,对于核苷类HIV-1RT抑制剂,取血时间要长,并同时测定血清在细胞内的活性,以便综合分析。 Objective:To observe the dynamics of HIV-1 reverse transcriptase (HIV-1 RT) inhibitor activity in serum of mice, and assess the applicability of the method in evaluating the activity of HIV-1 RT inhibitors. Methods: After mice were treated with HIV-1 RT inhibitors (with known or unknown constituents) through intragastric or intraperitoneal pathways, the activity of HIV-1 RT in serum of mice collected in different times was determined in vitro. Results: Serum of normal mice showed the non-specific inhibition on HIV-1 RT, but it could disappear when the serum was diluted. The inhibitory effects of HIV-1 RT in mice serum collected after given non-nucleotide reverse transcriptase inhibitors (NNRTIs) oould be well and immediately determined. But that in serum collected after given nucleotide reverse transcriptase inhibitors (NRTIs) was weak, because this kind of RT inhibitor could display the inhibition on HIV-1 RT only when it has been activated through phosphorylation in the cells and acts as competitive inhibitors. The degree of binding between drug and albumin, the bioactivity and the clearance rate of drugs can also be analyzed by this method. Conclusion: The in vitro and in vivo combined method for detection of RT inhibitor activity in mice serum could be applied in quick drug effect evaluation of HIV-1 NNRTIs. But as it is applied to determine the RT inhibitory activity of NRTIs, the blood collecting time should be delayed and the activity should be determined both in vitro and in vivo parallelly for a comprehensive analysis.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2003年第7期514-517,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 "九五"国家重点科技攻关项目延续(No.96-906-03-17)
关键词 艾滋病毒1型逆转录酶抑制剂 血清 药效评价 动物实验 HIV, reverse transcriptase-1, inhibitor, dynamic activity in mice serum, evaluation on drug efficacy
  • 相关文献

参考文献6

  • 1Oberg B.Antiviral effects of phosphonoformate(PFA,foscarnet sodium).Pharmacol Ther 1989;40(2):213—215.
  • 2Tang Xiao-shan,Chen Hong—shan,Zhang Xing-quan.Inhibition of human immunodeficiency virus reverse transcriptase by Chinese medicines in vitro.Proc.CAMS and PUMC 1990:3(5):140—144.
  • 3Campiani G,Ramunno A,Maga G,et a1.Non—nucleoside HIV-1 reverse transcriptase(RT)inhibitors:past,present and future perspectives.Curt Pharm Dis 2002;8(8):615—617.
  • 4Wientjes MG,Au JL.Lack of pharmacokinetic interaction between intravenous 2’,3'-dideoxyinosine and 3'-azido-3'-de.oxythymidine in rats.Antimicrob Agents Chemother 1992;36(3):665--668.
  • 5Schinazi RF,Boudinot FD,Doshi KJ,et al.Pharmacokinetics of 3'-fluoro-3’deoxythymidine and 3'-deoxy-2,3'-didehydrothymidine in rhesus monkeys.Antimicrob Agents Chemother 1990;34(6):1214--1219.
  • 6Riska PS,Joseph DP,Dinallo RM,et al.Biotransformation of nevirapine,a non-nucleoside HIV-1 reverse transcriptase inhibitor,in mice,rats,rabbits,dogs,monkeys,and chimpanzees.Drug Metab Dispos 1999;27(12):1434--1447.

同被引文献26

  • 1董飚,章天,陶佩珍.高通量荧光底物HIV-1蛋白酶模型的建立[J].中国艾滋病性病,2006,12(5):402-405. 被引量:4
  • 2陈鸿珊 阎旭光 张兴权 等.中药丹参体内外抗艾滋病和乙型肝炎病毒作用研究.中国医学科学院院学报,1996,18(6):3-3.
  • 3ABD-ELAZEM IS, CHEN HS, BATES RB, et al. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza [J]. Antiviral Res, 2002, 55(1) :91 - 106.
  • 4陈鸿珊,田庚元,吕刚,等.牛膝多糖硫酸酯的抗艾滋病和免疫调节新用途:中国,200510055374.4[P].2005-10-26.
  • 5郭志敏,陈鸿珊.HIV-1蛋白酶ELISA检测方法及用于多靶位筛选HIV-1抑制剂:中国,02124248.8[P].2003-03-19.
  • 6张兴权.抗艾滋病毒药物的研究方法[M]//陈鸿珊,张兴权.抗病毒药物及其研究方法.北京:化学工业出版社,2006:483-494.
  • 7RISKA PS, JOSEPH IS, P, DINALLO RM, et al. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees[ J]. Drug Metab Dispos, 1999, 27 ( 12 ) : 1434 - 1447.
  • 8ZHANG Y, AKAO T, NAKAMURA N, et al. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza in rat [ J ]. Planta Med, 2004,70 (2) :138 -142.
  • 9WU YT, CHEN YF, HSIEH YJ, et al. Bioavailability of salvianolic acid B in conscious and freely moving rats[ J]. Int J Pharm, 2006, 326(1/2) :25 -31.
  • 10Kashman Y, Gustafson KR, Fuller RW, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum [J]. J Med Chem, 1992,35:2735 -2743.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部